Enterprise technology vendors are racing to make AI work against the structured and relational data inside databases, data ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

Intelligence without integrity is just sophisticated risk. To build AI that lasts, you have to apply zero-trust principles to ...

By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...

The next important milestone for AI research is to automate model development. Every advance in reasoning, language, and perception is, in some sense, a step toward that goal. However, the path to ...

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

AI applications do not run on models alone. They run on timing. A support copilot, fraud system, recommendation engine, or AI ...

Tech stock declines highlight unsustainable AI spending; EssentaTor proposes Mapping Mathematics for durable, efficient intelligence systems.